|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Income from cash and investments held in trust account | |||||
| Depreciation and amortization | |||||
| Loss on impairment of long-lived assets | |||||
| Amortization of right-of-use assets | |||||
| Stock-based compensation | |||||
| Issuance of common stock to underwriter | |||||
| Change in provision for credit losses | |||||
| Change in fair value of warrant liabilities | |||||
| Recovery of offering costs attributable to warrant liability | |||||
| Loss from initial recognition of common stock forward liability | |||||
| Change in fair value of convertible promissory notes | |||||
| Change in fair value of common stock forward liability | |||||
| Gain on extinguishment of liability | |||||
| Changes in operating assets and liabilities: | |||||
| Expense reimbursement receivable from GCT | |||||
| Prepaid expenses | |||||
| Due to related party | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Contract assets | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Accrued and other current liabilities | |||||
| Net defined benefit liabilities | |||||
| Other taxes payable | |||||
| Income tax payable | |||||
| Accrued legal expense | |||||
| Accrued capital markets advisory expense | |||||
| Other accounts payable and accrued expenses | |||||
| Lease liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Cash withdrawn from trust account to pay taxes | |||||
| Cash withdrawn from trust account in connection with redemptions | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of promissory note to related party | |||||
| Redemption of common stock | |||||
| Proceeds from reverse recapitalization and PIPE Financing, net of transaction costs | |||||
| Proceeds from issuance of convertible promissory notes | |||||
| Proceeds from borrowings | |||||
| Proceeds from issuance of common stock under common stock purchase agreement | |||||
| Proceeds from issuance of common stock under at-market agreement | |||||
| Proceeds from issuance of common stock and common stock warrants in a private placement | |||||
| Proceeds from issuance of common stock and common stock warrants in a registered direct offering | |||||
| Proceeds from exercise of stock options | |||||
| Payment of common stock issuance costs | |||||
| Tax withholding on restricted stock units | |||||
| Repayments of borrowings | |||||
| Repayments of convertible promissory notes | |||||
| Payments of finance lease liabilities | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash paid for operating leases | |||||
| Non-cash financing activities: | |||||
| Increase in redemption value of shares subject to possible redemption | |||||
| Non-cash contribution - non-redemption agreements | |||||
| Partial waiver of deferred underwriter commission | |||||
| Excise tax payable attributable to redemption of common stock | |||||
| Conversion of Class B common stock to Class A common stock | |||||
| Extinguishment of debt | |||||
| Federal income tax paid | |||||
| Issuance of common stock from conversion of convertible promissory notes | |||||
| Issuance of common stock from cashless warrant exercise | |||||
| Settlement of common stock forward liability in equity | |||||
| Proceeds from issuance of common stock withheld for outstanding payables | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Purchase of property and equipment in accrued expenses and other current liabilities | |||||
Loading...